Rishon Lezion, Center District, Israel Related Funds
| Fund Name | Location |
| Anchor Group | Geneva, Geneve, Switzerland |
| BKCM | New York, New York, United States |
| Convoy Global Holdings | China, Hong Kong, Hong Kong Island |
| Cowen Healthcare Investments | New York, New York, United States |
| Drexel Hamilton, LLC | - |
| Nesnah Ventures LLC | La Crosse, United States, Wisconsin |
| Poplar Ventures | Kentucky, Louisville, United States |
| Prelude Trust | England, London, United Kingdom |
| Rockefeller Foundation | New York, New York, United States |
| Startupbootcamp FinTech Dubai | Dubai, United Arab Emirates |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nectin Therapeutics | $25M | 30 Nov 2022 | Jerusalem, Jerusalem District, Israel | ||
| $28M | 13 May 2021 | Jerusalem, Jerusalem District, Israel | |||
BioSight | $27M | 02 Dec 2020 | Israel, North District | ||
BioSight | $19M | 11 Mar 2020 | Israel, North District | ||
Ayala Pharmaceuticals | $30M | 28 May 2019 | Israel, Center District | ||
Biond Biologics | $17M | 08 Jan 2019 | Israel, North District | ||
Ayala Pharmaceuticals | $17M | 10 Apr 2018 | Israel, Center District | ||
| $30M | 27 Feb 2017 | Rishon Lezion, Center District, Israel | |||
Vidac Pharma | $9M | 29 Jun 2016 | Israel, Jerusalem District |
– Vensica closed an investment round of $16m.
– The round was led by Israel Biotech Fund (“IBF”), a venture fund investing in Israeli and Israeli-related biotechnology and pharmaceutical companies.
– Other investors in the round include Laborie, a global urology device company, Lew Pell, an experienced medical device investor, Agriline, a trust of which Vincent Tchenguiz is a discretionary beneficiary, and The Trendlines Group, an investor in innovation-based medical and agricultural technologies.
– Funds raised will support the company’s phase II multicenter clinical trials in Europe and the USA.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nectin Therapeutics | $25M | 30 Nov 2022 | Jerusalem, Jerusalem District, Israel | ||
| $28M | 13 May 2021 | Jerusalem, Jerusalem District, Israel | |||
BioSight | $27M | 02 Dec 2020 | Israel, North District | ||
BioSight | $19M | 11 Mar 2020 | Israel, North District | ||
Ayala Pharmaceuticals | $30M | 28 May 2019 | Israel, Center District | ||
Biond Biologics | $17M | 08 Jan 2019 | Israel, North District | ||
Ayala Pharmaceuticals | $17M | 10 Apr 2018 | Israel, Center District | ||
| $30M | 27 Feb 2017 | Rishon Lezion, Center District, Israel | |||
Vidac Pharma | $9M | 29 Jun 2016 | Israel, Jerusalem District |
